Traders purchased shares of Humana Inc. (NYSE:HUM) on weakness during trading on Friday. $253.27 million flowed into the stock on the tick-up and $235.94 million flowed out of the stock on the tick-down, for a money net flow of $17.33 million into the stock. Of all stocks tracked, Humana had the 3rd highest net in-flow for the day. Humana traded down ($4.59) for the day and closed at $158.15

A number of equities analysts recently commented on HUM shares. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a research note on Tuesday, April 12th. Leerink Swann reiterated an “outperform” rating on shares of Humana in a research note on Tuesday, April 5th. Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. Wolfe Research initiated coverage on Humana in a research note on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 target price for the company. Finally, Stifel Nicolaus lifted their target price on Humana from $209.00 to $220.00 and gave the company a “buy” rating in a research note on Thursday, May 5th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $206.00.

The firm has a 50 day moving average price of $180.60 and a 200-day moving average price of $175.55. The stock has a market capitalization of $23.57 billion and a PE ratio of 22.05.

Humana (NYSE:HUM) last released its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.81 by $0.05. During the same quarter in the previous year, the business posted $2.58 EPS. The company earned $13.80 billion during the quarter, compared to the consensus estimate of $13.80 billion. The firm’s quarterly revenue was down .2% on a year-over-year basis. Analysts predict that Humana Inc. will post $8.87 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Thursday, June 30th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.73%. The ex-dividend date is Tuesday, June 28th.

Several large investors recently added to or reduced their stakes in the stock. Nationwide Fund Advisors boosted its stake in Humana by 2.0% in the fourth quarter. Nationwide Fund Advisors now owns 44,613 shares of the insurance provider’s stock valued at $7,964,000 after buying an additional 877 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Humana by 1.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 42,043 shares of the insurance provider’s stock valued at $7,505,000 after buying an additional 537 shares during the period. Commerzbank Aktiengesellschaft FI raised its position in Humana by 52.0% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 8,869 shares of the insurance provider’s stock valued at $1,583,000 after buying an additional 3,035 shares during the period. ProShare Advisors LLC raised its position in Humana by 6.0% in the fourth quarter. ProShare Advisors LLC now owns 27,297 shares of the insurance provider’s stock valued at $4,873,000 after buying an additional 1,556 shares during the period. Finally, Comerica Bank raised its position in Humana by 1.3% in the fourth quarter. Comerica Bank now owns 36,810 shares of the insurance provider’s stock valued at $6,365,000 after buying an additional 460 shares during the period.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.